메뉴 건너뛰기




Volumn 11, Issue 4, 2015, Pages 703-712

Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: An expert panel consensus

Author keywords

basal cell carcinoma; locally advanced basal cell carcinoma; therapy; vismodegib

Indexed keywords

VISMODEGIB; ANILIDE; ANTINEOPLASTIC AGENT; PYRIDINE DERIVATIVE;

EID: 84923103884     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.14.281     Document Type: Review
Times cited : (50)

References (61)
  • 1
    • 84860322847 scopus 로고    scopus 로고
    • A systematic review of worldwide incidence of nonmelanoma skin cancer
    • Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br. J. Dermatol. 166(5), 1069-1080 (2012).
    • (2012) Br. J. Dermatol. , vol.166 , Issue.5 , pp. 1069-1080
    • Lomas, A.1    Leonardi-Bee, J.2    Bath-Hextall, F.3
  • 2
    • 84876738410 scopus 로고    scopus 로고
    • Basal cell carcinoma epidemiology in the UK: The elephant in the room
    • Levell NJ, Igali L, Wright KA et al. Basal cell carcinoma epidemiology in the UK: the elephant in the room. Clin. Exp. Dermatol. 38(4), 367-369 (2013).
    • (2013) Clin. Exp. Dermatol. , vol.38 , Issue.4 , pp. 367-369
    • Levell, N.J.1    Igali, L.2    Wright, K.A.3
  • 3
    • 84886722768 scopus 로고    scopus 로고
    • Age distribution of patients with advanced non-melanoma skin cancer in the United States
    • Dacosta Byfeld S, Chen D, Yim YM et al. Age distribution of patients with advanced non-melanoma skin cancer in the United States. Arch. Dermatol. Res. 305(9), 845-850 (2013).
    • (2013) Arch. Dermatol. Res. , vol.305 , Issue.9 , pp. 845-850
    • Dacosta Byfeld, S.1    Chen, D.2    Yim, Y.M.3
  • 4
    • 77649258546 scopus 로고    scopus 로고
    • Identifcation of the cell lineage at the origin of basal cell carcinoma
    • Youssef KK, Van Keymeulen A, Lapouge G et al. Identifcation of the cell lineage at the origin of basal cell carcinoma. Nat. Cell Biol. 12(3), 299-305 (2010).
    • (2010) Nat. Cell Biol. , vol.12 , Issue.3 , pp. 299-305
    • Youssef, K.K.1    Van Keymeulen, A.2    Lapouge, G.3
  • 5
    • 78651467232 scopus 로고    scopus 로고
    • Basal cell carcinomas arise from hair follicle stem cells in Ptch1(+/-) mice
    • Wang GY, Wang J, Mancianti ML et al. Basal cell carcinomas arise from hair follicle stem cells in Ptch1(+/-) mice. Cancer Cell 19(1), 114-124 (2011).
    • (2011) Cancer Cell , vol.19 , Issue.1 , pp. 114-124
    • Wang, G.Y.1    Wang, J.2    Mancianti, M.L.3
  • 6
    • 84864983740 scopus 로고    scopus 로고
    • Known and potential new risk factors for skin cancer in European populations: A multicentre case-control study
    • de Vries E, Trakatelli M, Kalabalikis D et al. Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study. Br. J. Dermatol. 167(Suppl 2), 1-13 (2012).
    • (2012) Br. J. Dermatol. , vol.167 , pp. 1-13
    • De Vries, E.1    Trakatelli, M.2    Kalabalikis, D.3
  • 8
    • 79959714409 scopus 로고    scopus 로고
    • Hereditary tumour syndromes featuring basal cell carcinomas
    • Parren LJ, Frank J. Hereditary tumour syndromes featuring basal cell carcinomas. Br. J. Dermatol. 165(1), 30-34 (2011).
    • (2011) Br. J. Dermatol. , vol.165 , Issue.1 , pp. 30-34
    • Parren, L.J.1    Frank, J.2
  • 10
    • 3042818253 scopus 로고    scopus 로고
    • Aggressive basal cell carcinoma: Presentation, pathogenesis, and management
    • Walling HW, Fosko SW, Geraminejad PA et al. Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metastasis Rev. 23(3-4), 389-402 (2004).
    • (2004) Cancer Metastasis Rev. , vol.23 , Issue.3-4 , pp. 389-402
    • Walling, H.W.1    Fosko, S.W.2    Geraminejad, P.A.3
  • 11
    • 0029977921 scopus 로고    scopus 로고
    • Platinum-based cytotoxic therapy in basal cell carcinoma-a review of the literature
    • Moeholt K, Aagaard H, Pfeiffer P, Hansen O. Platinum-based cytotoxic therapy in basal cell carcinoma-a review of the literature. Acta. Oncol. 35(6), 677-682 (1996).
    • (1996) Acta. Oncol. , vol.35 , Issue.6 , pp. 677-682
    • Moeholt, K.1    Aagaard, H.2    Pfeiffer, P.3    Hansen, O.4
  • 12
    • 16044363842 scopus 로고    scopus 로고
    • The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas
    • Gailani MR, Stahle-Backdahl M, Leffell DJ et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat. Genet. 14(1), 78-81 (1996).
    • (1996) Nat. Genet. , vol.14 , Issue.1 , pp. 78-81
    • Gailani, M.R.1    Stahle-Backdahl, M.2    Leffell, D.J.3
  • 13
    • 0031913524 scopus 로고    scopus 로고
    • Activating Smoothened mutations in sporadic basal-cell carcinoma
    • Xie J, Murone M, Luoh SM et al. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391(6662), 90-92 (1998).
    • (1998) Nature , vol.391 , Issue.6662 , pp. 90-92
    • Xie, J.1    Murone, M.2    Luoh, S.M.3
  • 14
    • 0031837549 scopus 로고    scopus 로고
    • Identifcation of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome
    • Aszterbaum M, Rothman A, Johnson RL et al. Identifcation of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J. Invest. Dermatol. 110(6), 885-888 (1998).
    • (1998) J. Invest. Dermatol. , vol.110 , Issue.6 , pp. 885-888
    • Aszterbaum, M.1    Rothman, A.2    Johnson, R.L.3
  • 15
    • 70349238733 scopus 로고    scopus 로고
    • Inhibition of the hedgehog pathway in advanced basal-cell carcinoma
    • Von Hoff DD, LoRusso PM, Rudin CM et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N. Engl. J. Med. 361(12), 1164-1172 (2009).
    • (2009) N. Engl. J. Med. , vol.361 , Issue.12 , pp. 1164-1172
    • Von Hoff, D.D.1    Lorusso, P.M.2    Rudin, C.M.3
  • 16
    • 79954611501 scopus 로고    scopus 로고
    • Phase i trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors
    • LoRusso PM, Rudin CM, Reddy JC et al. Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clin. Cancer Res. 17(8), 2502-2511 (2011).
    • (2011) Clin. Cancer Res. , vol.17 , Issue.8 , pp. 2502-2511
    • Lorusso, P.M.1    Rudin, C.M.2    Reddy, J.C.3
  • 17
    • 84861856844 scopus 로고    scopus 로고
    • Effcacy and safety of vismodegib in advanced basal-cell carcinoma
    • Sekulic A, Migden MR, Oro AE et al. Effcacy and safety of vismodegib in advanced basal-cell carcinoma. N. Engl. J. Med. 366(23), 2171-2179 (2012).
    • (2012) N. Engl. J. Med. , vol.366 , Issue.23 , pp. 2171-2179
    • Sekulic, A.1    Migden, M.R.2    Oro, A.E.3
  • 18
    • 84890796086 scopus 로고    scopus 로고
    • Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib
    • Chang AL, Solomon JA, Hainsworth JD et al. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib. J. Am. Acad. Dermatol. 70(1), 60-69 (2014).
    • (2014) J. Am. Acad. Dermatol. , vol.70 , Issue.1 , pp. 60-69
    • Chang, A.L.1    Solomon, J.A.2    Hainsworth, J.D.3
  • 19
    • 84861876867 scopus 로고    scopus 로고
    • Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome
    • Tang JY, Mackay-Wiggan JM, Aszterbaum M et al. Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N. Engl. J. Med. 366(23), 2180-2188 (2012).
    • (2012) N. Engl. J. Med. , vol.366 , Issue.23 , pp. 2180-2188
    • Tang, J.Y.1    Mackay-Wiggan, J.M.2    Aszterbaum, M.3
  • 20
    • 84869131318 scopus 로고    scopus 로고
    • Initial assessment of tumor regrowth after vismodegib in advanced Basal cell carcinoma
    • Chang AL, Oro AE. Initial assessment of tumor regrowth after vismodegib in advanced Basal cell carcinoma. Arch. Dermatol. 148(11), 1324-1325 (2012).
    • (2012) Arch. Dermatol. , vol.148 , Issue.11 , pp. 1324-1325
    • Chang, A.L.1    Oro, A.E.2
  • 21
    • 79960935826 scopus 로고    scopus 로고
    • Hedgehog fghts back: Mechanisms of acquired resistance against smoothened antagonists
    • Metcalfe C, de Sauvage FJ. Hedgehog fghts back: mechanisms of acquired resistance against smoothened antagonists. Cancer. Res. 71(15), 5057-5061 (2011).
    • (2011) Cancer. Res. , vol.71 , Issue.15 , pp. 5057-5061
    • Metcalfe, C.1    De Sauvage, F.J.2
  • 22
    • 84922479971 scopus 로고    scopus 로고
    • An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma
    • Ally MS, Aasi S, Wysong A et al. An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma. J. Am. Acad. Dermatol. 71(5), 904-911.e1 (2014).
    • (2014) J. Am. Acad. Dermatol. , vol.71 , Issue.5 , pp. 904-904e1
    • Ally, M.S.1    Aasi, S.2    Wysong, A.3
  • 23
    • 83655193541 scopus 로고    scopus 로고
    • Assessing current treatment options for patients with severe/advanced basal cell carcinoma
    • Weinstock MA, Still JM. Assessing current treatment options for patients with severe/advanced basal cell carcinoma. Semin. Cutan. Med. Surg. 30(Suppl 4), S10-S13 (2011).
    • (2011) Semin. Cutan. Med. Surg. , vol.30 , pp. S10-S13
    • Weinstock, M.A.1    Still, J.M.2
  • 24
    • 45749085217 scopus 로고    scopus 로고
    • Guidelines for the management of basal cell carcinoma
    • Telfer NR, Colver GB, Morton CA et al. Guidelines for the management of basal cell carcinoma. Br. J. Dermatol. 159(1), 35-48 (2008).
    • (2008) Br. J. Dermatol. , vol.159 , Issue.1 , pp. 35-48
    • Telfer, N.R.1    Colver, G.B.2    Morton, C.A.3
  • 25
    • 33845240594 scopus 로고    scopus 로고
    • European Dermatology Forum Guideline Committee. Guidelines: The management of basal cell carcinoma
    • Sterry W. European Dermatology Forum Guideline Committee. Guidelines: the management of basal cell carcinoma. Eur. J. Dermatol. 16(5), 476-478 (2006).
    • (2006) Eur. J. Dermatol. , vol.16 , Issue.5 , pp. 476-478
    • Sterry, W.1
  • 26
    • 33748329351 scopus 로고    scopus 로고
    • Management of basal cell carcinoma in adults clinical practice guidelines
    • Dandurand M, Petit T, Martel P et al. Management of basal cell carcinoma in adults clinical practice guidelines. Eur. J. Dermatol. 16(4), 394-401 (2006).
    • (2006) Eur. J. Dermatol. , vol.16 , Issue.4 , pp. 394-401
    • Dandurand, M.1    Petit, T.2    Martel, P.3
  • 29
    • 84923076746 scopus 로고    scopus 로고
    • Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Basal Cell and Squamous Cell Skin Cancers V.2. 2014. © National Comprehensive Cancer Network, Inc 2014. All rights reserved. To view the most recent and complete version of the guideline, go online to NCCN.org
    • Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Basal Cell and Squamous Cell Skin Cancers V.2.2014. © National Comprehensive Cancer Network, Inc 2014. All rights reserved. To view the most recent and complete version of the guideline, go online to NCCN.org.
  • 30
    • 85116183635 scopus 로고    scopus 로고
    • ®, and all other NCCN Content are trademarks owned by the National Comprehensive Cancer Network, Inc
    • ®, and all other NCCN Content are trademarks owned by the National Comprehensive Cancer Network, Inc.
  • 31
    • 84860697700 scopus 로고    scopus 로고
    • Treatment of facial Basal cell carcinoma: A review
    • Smith V, Walton S. Treatment of facial Basal cell carcinoma: a review. J. Skin. Cancer 2011, 380371 (2011).
    • (2011) J. Skin. Cancer , vol.2011 , pp. 380371
    • Smith, V.1    Walton, S.2
  • 32
    • 80054933475 scopus 로고    scopus 로고
    • 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma
    • Paoli J, Daryoni S, Wennberg AM et al. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma. Acta. Derm. Venereol. 91(6), 689-693 (2011).
    • (2011) Acta. Derm. Venereol. , vol.91 , Issue.6 , pp. 689-693
    • Paoli, J.1    Daryoni, S.2    Wennberg, A.M.3
  • 33
    • 0024538831 scopus 로고
    • Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: Implications for patient follow-up
    • Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J. Dermatol. Surg. Oncol. 15 (3), 315-328 (1989).
    • (1989) J. Dermatol. Surg. Oncol. , vol.15 , Issue.3 , pp. 315-328
    • Rowe, D.E.1    Carroll, R.J.2    Day, C.L.3
  • 34
    • 23944462707 scopus 로고    scopus 로고
    • Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up
    • Leibovitch I, Huilgol SC, Selva D et al. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J. Am. Acad. Dermatol. 53 (6), 452-457 (2005).
    • (2005) J. Am. Acad. Dermatol. , vol.53 , Issue.6 , pp. 452-457
    • Leibovitch, I.1    Huilgol, S.C.2    Selva, D.3
  • 35
    • 8444249009 scopus 로고    scopus 로고
    • Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: Randomised controlled trial
    • Smeets NW, Krekels GA, Ostertag JU et al. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet. 364 (9447), 1766-1772 (2004).
    • (2004) Lancet. , vol.364 , Issue.9447 , pp. 1766-1772
    • Smeets, N.W.1    Krekels, G.A.2    Ostertag, J.U.3
  • 36
    • 56449129112 scopus 로고    scopus 로고
    • Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: A prospective randomised controlled trial with 5-years' follow-up
    • Mosterd K, Krekels GA, Nieman FH et al. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol. 9 (12), 1149-1156 (2008).
    • (2008) Lancet Oncol. , vol.9 , Issue.12 , pp. 1149-1156
    • Mosterd, K.1    Krekels, G.A.2    Nieman, F.H.3
  • 37
    • 43549106828 scopus 로고    scopus 로고
    • The important role of radiotherapy in patients with non-melanoma skin cancer and other cutaneous entities
    • Veness MJ. The important role of radiotherapy in patients with non-melanoma skin cancer and other cutaneous entities. J. Med. Imaging Radiat. Oncol. 52(3), 278-286 (2008).
    • (2008) J. Med. Imaging Radiat. Oncol. , vol.52 , Issue.3 , pp. 278-286
    • Veness, M.J.1
  • 38
    • 70349961602 scopus 로고    scopus 로고
    • Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck
    • Mendenhall WM, Amdur RJ, Hinerman RW et al. Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope 119(10), 1994-1999 (2009).
    • (2009) Laryngoscope , vol.119 , Issue.10 , pp. 1994-1999
    • Mendenhall, W.M.1    Amdur, R.J.2    Hinerman, R.W.3
  • 39
    • 0035072819 scopus 로고    scopus 로고
    • Factors infuencing the linear depth of invasion of primary basal cell carcinoma
    • Takenouchi T, Nomoto S, Ito M. Factors infuencing the linear depth of invasion of primary basal cell carcinoma. Dermatol. Surg. 27(4), 393-396 (2001).
    • (2001) Dermatol. Surg. , vol.27 , Issue.4 , pp. 393-396
    • Takenouchi, T.1    Nomoto, S.2    Ito, M.3
  • 40
    • 33750303141 scopus 로고    scopus 로고
    • Factors affecting incomplete excision of nonmelanoma skin cancers in New Zealand
    • Bhatti AZ, Asif S, Alwan M. Factors affecting incomplete excision of nonmelanoma skin cancers in New Zealand. Ann. Plast. Surg. 57(5), 513-516 (2006).
    • (2006) Ann. Plast. Surg. , vol.57 , Issue.5 , pp. 513-516
    • Bhatti, A.Z.1    Asif, S.2    Alwan, M.3
  • 41
    • 84867793743 scopus 로고    scopus 로고
    • Nonmelanoma skin cancer of the head and neck: Surgical treatment
    • Akcam TM, Gubisch W, Unlu H. Nonmelanoma skin cancer of the head and neck: surgical treatment. Facial Plast. Surg. Clin. North Am. 20(4), 455-471 (2012).
    • (2012) Facial Plast. Surg. Clin. North Am. , vol.20 , Issue.4 , pp. 455-471
    • Akcam, T.M.1    Gubisch, W.2    Unlu, H.3
  • 43
    • 60449092062 scopus 로고    scopus 로고
    • Nonmelanoma skin cancer of the head and neck I: Histopathology and clinical behavior
    • McGuire JF, Ge NN, Dyson S. Nonmelanoma skin cancer of the head and neck I: histopathology and clinical behavior. Am. J. Otolaryngol. 30(2), 121-133 (2009).
    • (2009) Am. J. Otolaryngol. , vol.30 , Issue.2 , pp. 121-133
    • McGuire, J.F.1    Ge, N.N.2    Dyson, S.3
  • 45
    • 84875028343 scopus 로고    scopus 로고
    • Basosquamous cell carcinoma: A survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomas
    • Betti R, Crosti C, Ghiozzi S et al. Basosquamous cell carcinoma: a survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomas. Eur. J. Dermatol. 23(1), 83-86 (2013).
    • (2013) Eur. J. Dermatol. , vol.23 , Issue.1 , pp. 83-86
    • Betti, R.1    Crosti, C.2    Ghiozzi, S.3
  • 46
    • 0034653902 scopus 로고    scopus 로고
    • Basosquamous carcinoma: Analysis of prognostic factors infuencing recurrence
    • Martin RC 2nd, Edwards MJ, Cawte TG et al. Basosquamous carcinoma: analysis of prognostic factors infuencing recurrence. Cancer 88(6), 1365-1369 (2000).
    • (2000) Cancer , vol.88 , Issue.6 , pp. 1365-1369
    • Martin, R.C.1    Edwards, M.J.2    Cawte, T.G.3
  • 48
    • 76749096684 scopus 로고    scopus 로고
    • Non-melanoma skin cancer
    • Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet 375 (9715), 673-685 (2010).
    • (2010) Lancet , vol.375 , Issue.9715 , pp. 673-685
    • Madan, V.1    Lear, J.T.2    Szeimies, R.M.3
  • 49
    • 57249116889 scopus 로고    scopus 로고
    • Perineural invasion of cutaneous squamous cell carcinoma and basal cell carcinoma: Raising awareness and optimizing management
    • Geist DE, Garcia-Moliner M, Fitzek MM et al. Perineural invasion of cutaneous squamous cell carcinoma and basal cell carcinoma: raising awareness and optimizing management. Dermatol. Surg. 34(12), 1642-1651 (2008).
    • (2008) Dermatol. Surg. , vol.34 , Issue.12 , pp. 1642-1651
    • Geist, D.E.1    Garcia-Moliner, M.2    Fitzek, M.M.3
  • 50
    • 0034177932 scopus 로고    scopus 로고
    • Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery
    • Ratner D, Lowe L, Johnson TM et al. Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery. Cancer 88 (7), 1605-1613 (2000).
    • (2000) Cancer , vol.88 , Issue.7 , pp. 1605-1613
    • Ratner, D.1    Lowe, L.2    Johnson, T.M.3
  • 51
    • 0035869704 scopus 로고    scopus 로고
    • Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis
    • Williams LS, Mancuso AA, Mendenhall WM. Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis. Int. J. Radiat. Oncol. Biol. Phys. 49 (4), 1061-1069 (2001).
    • (2001) Int. J. Radiat. Oncol. Biol. Phys. , vol.49 , Issue.4 , pp. 1061-1069
    • Williams, L.S.1    Mancuso, A.A.2    Mendenhall, W.M.3
  • 52
    • 78349241980 scopus 로고    scopus 로고
    • Cutaneous squamous cell carcinoma and other cutaneous carcinomas
    • Springer, New York, NY, USA
    • American Joint Committee on Cancer. Cutaneous squamous cell carcinoma and other cutaneous carcinomas. In: AJCC Cancer Staging Manual (7th Edition). Edge SE, Byrd DR, Carducci MA et al. (Eds). Springer, New York, NY, USA, 301-314 (2010).
    • (2010) AJCC Cancer Staging Manual (7th Edition) , pp. 301-314
    • Edge, S.E.1    Byrd, D.R.2    Ma, C.3
  • 53
    • 80053389232 scopus 로고    scopus 로고
    • Carcinoma of the eyelid
    • Springer, New York, NY, USA
    • American Joint Committee on Cancer. Carcinoma of the eyelid. In: AJCC Cancer Staging Manual (7th Edition). Edge SE, Byrd DR, Carducci MA et al. (Eds). Springer, New York, NY, USA, 523-526 (2010).
    • (2010) AJCC Cancer Staging Manual (7th Edition) , pp. 523-526
    • Edge, S.E.1    Byrd, D.R.2    Ma, C.3
  • 54
    • 77952836149 scopus 로고    scopus 로고
    • Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital
    • Kyrgidis A, Vahtsevanos K, Tzellos TG et al. Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital. Eur. J. Dermatol. 20(3), 276-282 (2010).
    • (2010) Eur. J. Dermatol. , vol.20 , Issue.3 , pp. 276-282
    • Kyrgidis, A.1    Vahtsevanos, K.2    Tzellos, T.G.3
  • 55
    • 79956128912 scopus 로고    scopus 로고
    • Recurrence after treatment of nonmelanoma skin cancer: A prospective cohort study
    • Chren MM, Torres JS, Stuart SE et al. Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study. Arch. Dermatol. 147(5), 540-546 (2011).
    • (2011) Arch. Dermatol. , vol.147 , Issue.5 , pp. 540-546
    • Chren, M.M.1    Torres, J.S.2    Stuart, S.E.3
  • 56
    • 84876586267 scopus 로고    scopus 로고
    • Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma
    • Chren MM, Linos E, Torres JS et al. Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. J. Invest. Dermatol. 133(5), 1188-1196 (2013).
    • (2013) J. Invest. Dermatol. , vol.133 , Issue.5 , pp. 1188-1196
    • Chren, M.M.1    Linos, E.2    Torres, J.S.3
  • 57
    • 84877846412 scopus 로고    scopus 로고
    • Rerecurrence 5 years after treatment of recurrent cutaneous basal cell and squamous cell carcinoma
    • Hamilton JR, Parvataneni R, Stuart SE et al. Rerecurrence 5 years after treatment of recurrent cutaneous basal cell and squamous cell carcinoma. JAMA Dermatol. 149(5), 616-618 (2013).
    • (2013) JAMA Dermatol. , vol.149 , Issue.5 , pp. 616-618
    • Hamilton, J.R.1    Parvataneni, R.2    Stuart, S.E.3
  • 58
    • 84923088229 scopus 로고    scopus 로고
    • American Society of Anesthesiologists. ASA Physical Status Classifcation System
    • American Society of Anesthesiologists. ASA Physical Status Classifcation System. www.asahq.org
  • 59
    • 70350496540 scopus 로고    scopus 로고
    • Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma
    • Yauch RL, Dijkgraaf GJ, Alicke B et al. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326(5952), 572-574 (2009).
    • (2009) Science , vol.326 , Issue.5952 , pp. 572-574
    • Yauch, R.L.1    Dijkgraaf, G.J.2    Alicke, B.3
  • 60
    • 77950492233 scopus 로고    scopus 로고
    • Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth
    • Kim J, Tang JY, Gong R et al. Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell. 17(4), 388-99 (2010).
    • (2010) Cancer Cell. , vol.17 , Issue.4 , pp. 388-399
    • Kim, J.1    Tang, J.Y.2    Gong, R.3
  • 61
    • 84872417679 scopus 로고    scopus 로고
    • Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists
    • Kim J, Aftab BT, Tang JY et al. Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists. Cancer Cell. 23(1), 23-34 (2013).
    • (2013) Cancer Cell. , vol.23 , Issue.1 , pp. 23-34
    • Kim, J.1    Aftab, B.T.2    Tang, J.Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.